DK0957165T3 - Optimering af celler til endogen genaktivering - Google Patents

Optimering af celler til endogen genaktivering

Info

Publication number
DK0957165T3
DK0957165T3 DK99112607T DK99112607T DK0957165T3 DK 0957165 T3 DK0957165 T3 DK 0957165T3 DK 99112607 T DK99112607 T DK 99112607T DK 99112607 T DK99112607 T DK 99112607T DK 0957165 T3 DK0957165 T3 DK 0957165T3
Authority
DK
Denmark
Prior art keywords
optimization
cells
endogenous gene
gene activation
activation
Prior art date
Application number
DK99112607T
Other languages
Danish (da)
English (en)
Inventor
Konrad Honold
Thomas Holtschke
Anne Stern
Original Assignee
Roche Diagnostics Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8227717&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0957165(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Roche Diagnostics Gmbh filed Critical Roche Diagnostics Gmbh
Application granted granted Critical
Publication of DK0957165T3 publication Critical patent/DK0957165T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475Growth factors; Growth regulators
    • C07K14/505Erythropoietin [EPO]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/65Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression using markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/87Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90Stable introduction of foreign DNA into chromosome
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/87Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90Stable introduction of foreign DNA into chromosome
    • C12N15/902Stable introduction of foreign DNA into chromosome using homologous recombination
    • C12N15/907Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6897Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00Nucleic acids vectors
    • C12N2800/30Vector systems comprising sequences for excision in presence of a recombinase, e.g. loxP or FRT
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00Vector systems having a special element relevant for transcription
    • C12N2830/001Vector systems having a special element relevant for transcription controllable enhancer/promoter combination
    • C12N2830/002Vector systems having a special element relevant for transcription controllable enhancer/promoter combination inducible enhancer/promoter combination, e.g. hypoxia, iron, transcription factor

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK99112607T 1997-12-01 1998-12-01 Optimering af celler til endogen genaktivering DK0957165T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97121075 1997-12-01
EP98122807.5A EP0919619B2 (fr) 1997-12-01 1998-12-01 Optimalisation de cellules pour l'activation de l'expression de gènes endogènes

Publications (1)

Publication Number Publication Date
DK0957165T3 true DK0957165T3 (da) 2007-07-30

Family

ID=8227717

Family Applications (3)

Application Number Title Priority Date Filing Date
DK99112607T DK0957165T3 (da) 1997-12-01 1998-12-01 Optimering af celler til endogen genaktivering
DK04006966T DK1464705T3 (da) 1997-12-01 1998-12-01 Optimering af celler til endogen genaktivering
DK98122807.5T DK0919619T4 (da) 1997-12-01 1998-12-01 Optimering af celler til endogen genaktivering

Family Applications After (2)

Application Number Title Priority Date Filing Date
DK04006966T DK1464705T3 (da) 1997-12-01 1998-12-01 Optimering af celler til endogen genaktivering
DK98122807.5T DK0919619T4 (da) 1997-12-01 1998-12-01 Optimering af celler til endogen genaktivering

Country Status (16)

Country Link
US (1) US7008764B1 (fr)
EP (3) EP0957165B1 (fr)
JP (1) JP4629813B2 (fr)
KR (1) KR100367062B1 (fr)
CN (2) CN100519751C (fr)
AR (4) AR018022A1 (fr)
AT (3) ATE318904T1 (fr)
AU (1) AU757930B2 (fr)
BR (1) BR9805682A (fr)
CA (1) CA2252970C (fr)
DE (3) DE59813413D1 (fr)
DK (3) DK0957165T3 (fr)
ES (3) ES2284228T3 (fr)
PT (3) PT957165E (fr)
TR (1) TR199802503A2 (fr)
ZA (1) ZA9810915B (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6316253B1 (en) 1999-11-01 2001-11-13 Chiron Corporation Expression vectors, transfection systems, and method of use thereof
WO2001066717A2 (fr) * 2000-03-03 2001-09-13 The University Of Utah Procede de ciblage genique
DE10023887A1 (de) * 2000-05-17 2001-11-29 Axel Haverich Verfahren zur transienten Insertion genetischer Elemente
CA2455013A1 (fr) * 2001-07-27 2003-02-13 Francesca Storici Systemes utilisant des oligonucleotides pour une mutagenese dirigee in vivo
AU2003251286B2 (en) 2002-01-23 2007-08-16 The University Of Utah Research Foundation Targeted chromosomal mutagenesis using zinc finger nucleases
CA2497913C (fr) 2002-09-05 2014-06-03 California Institute Of Technology Utilisation de nucleases chimeres pour stimuler le ciblage de genes
US8409861B2 (en) 2003-08-08 2013-04-02 Sangamo Biosciences, Inc. Targeted deletion of cellular DNA sequences
US7888121B2 (en) 2003-08-08 2011-02-15 Sangamo Biosciences, Inc. Methods and compositions for targeted cleavage and recombination
US11311574B2 (en) 2003-08-08 2022-04-26 Sangamo Therapeutics, Inc. Methods and compositions for targeted cleavage and recombination
US20120196370A1 (en) 2010-12-03 2012-08-02 Fyodor Urnov Methods and compositions for targeted genomic deletion
US7972854B2 (en) 2004-02-05 2011-07-05 Sangamo Biosciences, Inc. Methods and compositions for targeted cleavage and recombination
CA2579677A1 (fr) * 2004-09-16 2006-03-30 Sangamo Biosciences, Inc. Production de proteines: compositions et methodes
WO2007014275A2 (fr) * 2005-07-26 2007-02-01 Sangamo Biosciences, Inc. Integration et expression ciblees de sequences d'acides nucleiques exogenes
CN103484496A (zh) * 2013-07-31 2014-01-01 新乡医学院 一种报告基因重组在染色体目的基因上的方法、位点及用途
US10006910B2 (en) 2014-12-18 2018-06-26 Agilome, Inc. Chemically-sensitive field effect transistors, systems, and methods for manufacturing and using the same
US9857328B2 (en) 2014-12-18 2018-01-02 Agilome, Inc. Chemically-sensitive field effect transistors, systems and methods for manufacturing and using the same
US9618474B2 (en) 2014-12-18 2017-04-11 Edico Genome, Inc. Graphene FET devices, systems, and methods of using the same for sequencing nucleic acids
US10020300B2 (en) 2014-12-18 2018-07-10 Agilome, Inc. Graphene FET devices, systems, and methods of using the same for sequencing nucleic acids
US9859394B2 (en) 2014-12-18 2018-01-02 Agilome, Inc. Graphene FET devices, systems, and methods of using the same for sequencing nucleic acids
EP3235010A4 (fr) 2014-12-18 2018-08-29 Agilome, Inc. Transistor à effet de champ chimiquement sensible
WO2017201081A1 (fr) 2016-05-16 2017-11-23 Agilome, Inc. Dispositifs à fet au graphène, systèmes et leurs méthodes d'utilisation pour le séquençage d'acides nucléiques

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US568772A (en) * 1896-10-06 Albert s
CA1293460C (fr) * 1985-10-07 1991-12-24 Brian Lee Sauer Recombinaison a des sites specifiques de l'adn dans les levures
GB2187415A (en) 1986-03-05 1987-09-09 Deere & Co Machine for forming cylindrical bales of crop
JPS62265992A (ja) * 1986-05-12 1987-11-18 Ajinomoto Co Inc ヒト細胞を用いる有用物質の製造方法
US4956288A (en) * 1988-04-22 1990-09-11 Biogen, Inc. Method for producing cells containing stably integrated foreign DNA at a high copy number, the cells produced by this method, and the use of these cells to produce the polypeptides coded for by the foreign DNA
FR2646438B1 (fr) * 1989-03-20 2007-11-02 Pasteur Institut Procede de remplacement specifique d'une copie d'un gene present dans le genome receveur par l'integration d'un gene different de celui ou se fait l'integration
DE69032809T2 (de) * 1989-11-06 1999-07-08 Cell Genesys Inc Herstellung von Proteinen mittels homologer Rekombination
US5272071A (en) * 1989-12-22 1993-12-21 Applied Research Systems Ars Holding N.V. Method for the modification of the expression characteristics of an endogenous gene of a given cell line
EP0779362B2 (fr) * 1989-12-22 2012-06-13 Laboratoires Serono SA Constructions de type ADN pour l'activation et la modification de l'expression de gènes endogènes
WO1992015694A1 (fr) * 1991-03-08 1992-09-17 The Salk Institute For Biological Studies Modification de genes induite par recombinase dans des cellules de mammifere, compositions et cellules utiles a cet effet
US6270989B1 (en) * 1991-11-05 2001-08-07 Transkaryotic Therapies, Inc. Protein production and delivery
EP0626999A4 (en) * 1992-01-24 1997-04-09 Life Technologies Inc Modulation of enzyme activities in the -i(in vivo) cloning of dna.
TW402639B (en) * 1992-12-03 2000-08-21 Transkaryotic Therapies Inc Protein production and protein delivery
US5527695A (en) * 1993-01-29 1996-06-18 Purdue Research Foundation Controlled modification of eukaryotic genomes
ATE244311T1 (de) * 1993-12-23 2003-07-15 Merck & Co Inc Expressionssystem von antikörpern bei homologischer rekombinierung in murinezellen
US6130364A (en) * 1995-03-29 2000-10-10 Abgenix, Inc. Production of antibodies using Cre-mediated site-specific recombination
US5882914A (en) 1995-06-06 1999-03-16 The Johns Hopkins University School Of Medicine Nucleic acids encoding the hypoxia inducible factor-1
US5695977A (en) * 1995-08-31 1997-12-09 Genetic Information Research Institute Site directed recombination
AUPN903196A0 (en) * 1996-03-29 1996-04-26 Australian National University, The Single-step excision means
US6020144A (en) * 1996-09-12 2000-02-01 Symbiontics, Inc. Sustained delivery device comprising a Leishmania protozoa and methods of making and using the same

Also Published As

Publication number Publication date
DE59813413D1 (de) 2006-04-27
ZA9810915B (en) 2000-05-30
DE59813976D1 (de) 2007-05-31
US7008764B1 (en) 2006-03-07
CN1590551A (zh) 2005-03-09
CA2252970C (fr) 2011-11-15
EP0957165A3 (fr) 2000-10-04
AU9328498A (en) 1999-06-17
AR020893A2 (es) 2002-06-05
EP0919619B2 (fr) 2013-06-19
ES2259422T3 (es) 2006-10-01
ATE360067T1 (de) 2007-05-15
TR199802503A3 (tr) 1999-06-21
EP0957165A2 (fr) 1999-11-17
ATE320491T1 (de) 2006-04-15
AU757930B2 (en) 2003-03-13
ES2258809T3 (es) 2006-09-01
ES2258809T5 (es) 2013-09-05
PT919619E (pt) 2006-07-31
AR020750A2 (es) 2002-05-29
CN1240829A (zh) 2000-01-12
EP0919619A2 (fr) 1999-06-02
PT1464705E (pt) 2006-08-31
KR100367062B1 (ko) 2004-05-31
EP0919619A3 (fr) 1999-07-21
DK0919619T4 (da) 2013-09-23
DK1464705T3 (da) 2006-07-24
ES2284228T3 (es) 2007-11-01
CA2252970A1 (fr) 1999-06-01
AR018022A1 (es) 2001-10-31
DK0919619T3 (da) 2006-07-10
JP4629813B2 (ja) 2011-02-09
CN100519751C (zh) 2009-07-29
KR19990062655A (ko) 1999-07-26
PT957165E (pt) 2007-07-19
TR199802503A2 (xx) 1999-06-21
DE59813438D1 (de) 2006-05-11
CN1232644C (zh) 2005-12-21
AR020892A2 (es) 2002-06-05
JPH11225785A (ja) 1999-08-24
EP0919619B1 (fr) 2006-03-01
EP0957165B1 (fr) 2007-04-18
EP1464705B1 (fr) 2006-03-15
ATE318904T1 (de) 2006-03-15
EP1464705A1 (fr) 2004-10-06
BR9805682A (pt) 2000-04-11

Similar Documents

Publication Publication Date Title
DK0919619T3 (da) Optimering af celler til endogen genaktivering
ID19961A (id) Sel jenis tipis
DE69824784D1 (de) Brennstoffzelle
DE59809094D1 (de) Brennstoffzellensystem
DE69831948D1 (de) Selbständiges zellwachstumssystem
ID24612A (id) Hidrogenolisis gliserol
DE69806599T2 (de) Multipel-flammpunkt-verdampfungssystem
DK1005517T3 (da) Fremgangsmåde til fremstilling af diglycerider
DE69832046D1 (de) Elektrolytische feststoffzelle
DE69839754D1 (de) Kurzzellenmultiplexer
DE69841343D1 (de) Festelektrolytzelle
DE59803169D1 (de) Bearbeitungszelle
NO994450D0 (no) Kretskortfeste
DE69825282D1 (de) Unterstützungsystem
DE69835919D1 (de) Programmaufbauunterstützungssystem
DE69825647D1 (de) Befestigungssytem
DE69813680D1 (de) Gruppenantenne unter Verwendung von Verzögerungsleitungen
DE69835316D1 (de) Festelektrolyt
DK0927766T3 (da) Enzymatisk fremgangsmåde til fremstilling af (S)-cyanhydriner
DE69821325D1 (de) Baustütze
DK2281892T3 (da) Fremgangsmåde til fremstilling af respiratorisk-deficiente Trichoderma-celler
DK0951561T3 (da) Enzymatiske fremgangsmåder til fremstilling af (S)-cyanhydriner
DE69825927D1 (de) Fixiereinrichtung
IT1291111B1 (it) Ubiquitina-isopeptidasi di mammifero che controllano la proliferazione cellulare
DE69838302D1 (de) Gruppenlaufzeitentzerrer